Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.03
-0.12 (-1.95%)
Sep 11, 2026, 2:44 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 499.97 million as of September 11, 2026. Its market cap has increased by 21.82% in one year.
Market Cap
499.97M
Enterprise Value
4.46B
Revenue
763.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.03
ChartMarket Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 499.97M, a decrease of -51.93%. That is a compound annual growth rate of -3.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 499.97M | -65.87% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anlon Healthcare | 8.65B |
| Amanta Healthcare | 7.84B |
| Bafna Pharmaceuticals | 7.28B |
| Valiant Laboratories | 6.51B |
| Nectar Lifesciences | 2.36B |
| Brooks Laboratories | 1.86B |
| Par Drugs and Chemicals | 1.65B |
| Alpa Laboratories | 1.33B |